Skip to main content
Thursday
February 02, 2023
Sign In
Subscribe
Home
Economy
Aviation
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
World+Biz
Sports
Features
Book Review
Brands
Earth
Explorer
Fact Check
Family
Food
Game Reviews
Good Practices
Habitat
Humour
In Focus
Luxury
Mode
Panorama
Pursuit
Wealth
Wellbeing
Wheels
Epaper
More
Subscribe
Videos
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
COVID-19
Games
Long Read
Interviews
Offbeat
Podcast
Quiz
Tech
Trial By Trivia
Magazine
বাংলা
THURSDAY,
FEBRUARY 02, 2023
J&J
World+Biz
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
Coronavirus chronicle
No Omicron deaths in J&J vaccine study in South Africa, scientist says
Global Economy
Healthcare giant Johnson & Johnson to split into two companies
Coronavirus chronicle
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
USA
J&J settles most Risperdal lawsuits, with $800 million in expenses
Coronavirus chronicle
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Coronavirus chronicle
Moderna or Pfizer booster works better for people vaccinated with J&J: study
USA
Six US states do not join $26 billion opioid settlements with distributors, J&J
Coronavirus chronicle
J&J says US FDA agrees to extend shelf life of its Covid-19 vaccine
World+Biz
J&J exploring putting talc liabilities into bankruptcy
World+Biz
J&J reaches $230 mln opioid settlement with New York state
Panorama
The real vaccine crisis isn’t about J&J or AstraZeneca
Coronavirus chronicle
J&J to deliver Covid vaccine to Europe from April 19
Show More